- Seromucinous component in endometrioid endometrial carcinoma as a histological predictor of prognosis
-
Miyamoto M, Takano M, Aoyama T, Soyama H, Yoshikawa , Tsuda H, Furuya K
- KMID: 2404015
- J Gynecol Oncol.
- 2018 Mar;29(2):e20.
- doi: 10.3802/jgo.2018.29.e20
OBJECTIVE: In 2014 World Health Organization criteria, seromucinous carcinoma was defined as a new histological subtype in ovarian carcinomas, but “seromucinous carcinoma†was not defined in endometrial carcinomas. The aim... -
- CITED
-
- Close
- SHARE
-
- Close
- Surgical Outcomes of High-Grade Spinal Cord Gliomas
-
Seki T, Hida K, Yano S, Aoyama T, Koyanagi I, Houkin K
- KMID: 2131118
- Asian Spine J.
- 2015 Dec;9(6):935-941.
- doi: 10.4184/asj.2015.9.6.935
STUDY DESIGN: A retrospective study. PURPOSE: The purpose of this study was to obtain useful information for establishing the guidelines for treating high-grade spinal cord gliomas. OVERVIEW OF LITERATURE: The optimal management... -
- CITED
-
- Close
- SHARE
-
- Close
- Inhibition of autophagy protein LC3A as a therapeutic target in ovarian clear cell carcinomas
-
Miyamoto M, Takano M, Aoyama T, Soyama H, Yoshikawa , Tsuda H, Furuya K
- KMID: 2413444
- J Gynecol Oncol.
- 2017 May;28(3):e33.
- doi: 10.3802/jgo.2017.28.e33
OBJECTIVE: Ovarian clear cell carcinoma (CCC) is one of histological subtypes showing poor prognosis due to chemoresistance. The association of autophagy-related proteins and clinical implementation in CCC has not been... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Factors for Prognosis and Treatment Guidance of Spinal Cord Astrocytoma
-
Seki T, Hida K, Yano S, Aoyama T, Koyanagi I, Sasamori T, Hamauch S, Houkin K
- KMID: 2349300
- Asian Spine J.
- 2016 Aug;10(4):748-754.
- doi: 10.4184/asj.2016.10.4.748
STUDY DESIGN: Retrospective study. PURPOSE: To obtain information useful in establishing treatment guidelines by evaluating baseline clinical features and treatment outcomes of patients with spinal cord astrocytoma (SCA). OVERVIEW OF LITERATURE: The... -
- CITED
-
- Close
- SHARE
-
- Close
